Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Herbert Wiedemann, MD


Herbert Wiedemann, MD

Appointed: 1984

No Patient Satisfaction Reviews
Herbert Wiedemann, MD
Department: Pulmonary Medicine
Institute Chair
Location: Cleveland Clinic Main Campus
Mail Code A90
9500 Euclid Avenue
Cleveland, OH 44195
Herbert Wiedemann, MD
Department: Critical Care Medicine
Location: Cleveland Clinic Main Campus
Mail Code A90
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Adults Only

Biographical Sketch

Herbert P. Wiedemann, MD, MBA, is Chairman of the Cleveland Clinic Respiratory Institute as well as Chairman of the Department of Pulmonary, Allergy & Critical Care Medicine, a position he has held since 1991. Dr. Wiedemann also served a five-year term on Cleveland Clinic's Board of Governors (2001-2006).

He is board-certified in internal medicine, pulmonary disease, and critical care medicine, Dr. Wiedemann's clinical interests are intensive care medicine (including acute respiratory distress syndrome and sepsis) and the evaluation of dyspnea (including cardiopulmonary exercise testing).

Dr. Wiedemann has been the recipient of many awards including The Best Doctors in America, America's Top Doctors, Who's Who in Medicine and Healthcare, and Who's Who in America. Dr. Wiedemann has participated in several large multicenter trials of new therapies for acute respiratory distress syndrome (ARDS) and sepsis, and he served as principal investigator for three of these trials.

In addition, Dr. Wiedemann is a journal reviewer for many peer-reviewed publications including New England Journal of Medicine, Annals of Internal Medicine, Chest, European Respiratory Journal, and Journal of Intensive Care Medicine. He is a member or fellow of the American College of Chest Physicians, the American College of Critical Care Medicine and the American College of Physicians. Dr. Wiedemann also has taught as a visiting professor at many national and international universities.

After receiving his B.S degree from Yale, and medical degree from Cornell University College of Medicine in New York City, Dr. Wiedemann completed his internship and residency in internal medicine at the University of Washington Medical Center in Seattle, where he also served as chief medical resident. He completed his fellowship in pulmonary and critical care medicine at Yale University in Haven Hospital in Connecticut. Dr. Wiedemann has also received an M.B.A. degree from the Yale University School of Management.

Education & Fellowships

Graduate - Yale University
New Haven, CT USA
Fellowship - Yale-New Haven Hospital
New Haven, CT USA
Residency - Harborview Medical Center
IM Chief Resident
Seattle, WA USA
Residency - University of Washington Medical Center
Internal Medicine
Seattle, WA USA
Internship - University of Washington Medical Center
Seattle, WA USA
Medical School - Cornell University Medical College
New York, NY USA
Undergraduate - Yale University
New Haven, CT USA


  • Internal Medicine
  • Internal Medicine- Pulmonary Disease

Specialty Interests

Acute lung injury, acute respiratory distress syndrome(ARDS), asthma, bronchitis, chronic obstructive pulmonary disease (COPD), emphysema, histoplasmosis, lung cancer, pulmonary disease, sepsis

Awards & Honors

  • Dr. Wiedemann is included in "The Best Doctors in America" (Woodward/White, Inc.) since 1992, "America's Top Doctors" (Castle Connolly Medical. LTD.) since 2001, "Who's Who in America" (Marquis, Inc.) since 1997, and "Who's Who in the World" (Marquis, Inc) since 1998.
  • Dr. Wiedemann has received continuous funding from the National Institutes of Health (NIH) since 1994 in his role as site Principal Investigator at the Cleveland Clinic for participation in the Acute Respiratory Distress Syndrome (ARDS) Clinical Trial Network.


  • Fellow, American College of Physicians
  • Fellow, American College of Chest Physicians
  • Fellow, American College of Critical Care Medicine
  • American Thoracic Society
  • American College of Physician Executives

Treatment & Services

  • Bronchoscopy
  • Clinical Trials
  • Endotracheal Intubation
  • Mechanical Ventilation
  • Treating Asthma With Bronchodilators

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/30/2016, Dr. Wiedemann has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English